Chemours is a global $6 billion company specialising in Titanium Dioxide products. That is big-boy territory, and for a tiny MC-$20m R&D stock to have entered into a production agreement with them can only be a big plus for UTR.
It doesn't guarantee anything, but it could save UTR (and us!) an absolute packet vis a vis bringing the product to end users for discovery, and even further if the product gets taken up by manufacturers. Interesting times ahead
UTR Price at posting:
3.2¢ Sentiment: Buy Disclosure: Held
